ICU MEDICAL INC/DE

ICU MEDICAL INC/DE (ICUI) is a publicly listed company on US equity markets.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

The company reports trailing twelve-month revenue of $530.23M and net income of $30.13M.

Key metrics include a return on equity of 1.4%.

Use FINOTAUR to track ICUI's price action, review fundamentals, and stay current with company news — all in one research dashboard.